Trial intelligence / Profile preview

VVZ-149 for Postoperative Pain Following Bunionectomy

NCT03997812Phase 2Completed

Sponsor
Vivozon
Start
May 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of opiranserin in postoperative pain, sponsored by Vivozon. Started May 2019; status: completed.

02

Drugs

opiranserin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03997812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03997812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call